Since both macrophages and T cells are involved in the pathogenesis of RA, systemic inhibition of macrophage/T cell activation via downregulating IL-15 and IL-2 signaling may result in an enhanced anti-arthritic effect. This evidence concerns the gene IL2 and rheumatoid arthritis.